Lipid-lowering: Can ezetimibe help close the treatment gap?

Ryan C. Neal, Peter H. Jones

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Most patients who should be on lipid-lowering therapy are not receiving it, and most patients who are receiving it are not reaching their appropriate low-density lipoprotein (LDL) goals. This is in part because physicians and patients fear side effects of statins and other lipid-lowering agents. Ezetimibe (Zetia), a new lipid-lowering drug, may help physicians close this "treatment gap" in more patients, especially in combination with a statin.

Original languageEnglish (US)
Pages (from-to)777-783
Number of pages7
JournalCleveland Clinic journal of medicine
Issue number9
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Lipid-lowering: Can ezetimibe help close the treatment gap?'. Together they form a unique fingerprint.

Cite this